# Financial Toxicity in Radiation Oncology

**Authors:** Kanchan Gupta, Bhupesh Parashar

PMC · DOI: 10.7759/cureus.58643 · Cureus · 2024-04-20

## TL;DR

This paper reviews the financial burden cancer patients, especially those undergoing radiation therapy, face due to medical costs and explores related factors and solutions.

## Contribution

The paper provides a concise overview of financial toxicity in radiation oncology, including risk factors, tools, and interventions.

## Key findings

- Cancer patients undergoing radiation therapy face higher financial burdens than healthy individuals.
- Multiple tools exist to assess financial toxicity in patients.
- Interventions can help mitigate the economic impact of cancer treatment.

## Abstract

Financial toxicity details the financial burden patients face due to a variety of medical costs. Cancer patients, especially those receiving radiation therapy, are at a much higher risk of experiencing economic hardships than healthy people or people with other conditions. There are a variety of risk factors associated with financial toxicity as well as numerous tools to assess the toxicity experienced by patients. In this review article, we present a concise overview of contributors, risk factors, case studies, tools, impacts, and potential interventions of financial toxicity.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** Toxicity (MESH:D064420), Radiation Oncology (MESH:D011832), Cancer (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11032110/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC11032110/full.md

---
Source: https://tomesphere.com/paper/PMC11032110